Mobic’s blockbuster potential follows COX-2 bad news
Sales of Mobic nearly tripled to $258 million in the fourth quarter of 2004, exceeding most Wall Street estimates by at least $100 million.
Mobic, originally estimated to be a moderate seller, is now expected to achieve blockbuster status with a potential for $1 billion in sales, Abbott said detailing its fourth quarter earnings this week.
The news also is a boon for Germany's Boehringer Ingelheim, which licensed Mobic to Abbott in a co-marketing agreement. The terms of that agreement are slated to change in April, with more Mobic profits going to Boehringer.